Neu Base Therapeutics Inc (NBSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2022 | 09-2021 | 09-2020 | 09-2019 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -33,777 | -25,409 | -17,385 | -26,132 | -13,237 |
| Depreciation Amortization | 1,263 | 576 | 281 | 245 | 7,179 |
| Other Working Capital | 177 | 361 | 479 | 623 | -2,786 |
| Other Operating Activity | 3,325 | 5,599 | 5,915 | 22,419 | -648 |
| Operating Cash Flow | $-29,012 | $-18,874 | $-10,710 | $-2,846 | $-9,492 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 0 | -25 | N/A | N/A | N/A |
| PPE Investments | -472 | -1,438 | -717 | -455 | 528 |
| Net Acquisitions | N/A | -1,100 | N/A | -133 | N/A |
| Other Investing Activity | 0 | 0 | 0 | -97 | 0 |
| Investing Cash Flow | $-472 | $-2,564 | $-717 | $-685 | $528 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 600 | N/A |
| Debt Repayment | -110 | -9 | N/A | N/A | N/A |
| Common Stock Issued | 1 | 42,729 | 33,455 | 13,227 | 270 |
| Other Financing Activity | -148 | -382 | -350 | -232 | -356 |
| Financing Cash Flow | $-257 | $42,338 | $33,105 | $13,595 | $-86 |
| Beginning Cash Position | 52,893 | 31,992 | 10,314 | 250 | 12,801 |
| End Cash Position | 23,153 | 52,893 | 31,992 | 10,314 | 3,750 |
| Net Cash Flow | $-29,741 | $20,901 | $21,678 | $10,064 | $-9,051 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,012 | -18,874 | -10,710 | -2,846 | -9,492 |
| Capital Expenditure | -472 | -1,438 | -717 | -455 | N/A |
| Free Cash Flow | -29,484 | -20,312 | -11,427 | -3,301 | -9,492 |